Renaissance Technologies (RenTech)'s SLNO Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 447,300 shares of Soleno Therapeutics, Inc. (SLNO) worth $14.98 M, representing 0.02% of the portfolio. First purchased in 2019-Q1, this long-term strategic position has been held for 21 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in SLNO, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 447,300 shares. Largest reduction occurred in Q4 2023, reducing 61,554 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Soleno Therapeutics (SLNO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Soleno Therapeutics (SLNO) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +447,300 | New Buy | 447,300 | $33.48 |
| Q3 2025 | -45,200 | Sold Out | 0 | $0.00 |
| Q2 2025 | +45,200 | New Buy | 45,200 | $83.78 |
| Q4 2023 | -61,554 | Sold Out | 0 | $0.00 |
| Q3 2023 | -4,500 | Reduce 6.81% | 61,554 | $29.50 |
| Q2 2023 | -10,461 | Reduce 13.67% | 66,054 | $0.00 |
| Q1 2023 | +26,761 | Add 53.79% | 76,515 | $0.00 |
| Q4 2022 | +4,800 | Add 10.68% | 49,754 | $0.00 |
| Q3 2022 | +8,279 | Add 22.57% | 44,954 | $1.67 |
| Q2 2022 | +20,128 | Add 121.64% | 36,675 | $2.78 |
| Q1 2022 | +12,507 | Add 309.58% | 16,547 | $3.32 |
| Q4 2021 | +3,347 | Add 482.97% | 4,040 | $6.19 |
| Q3 2021 | -24,253 | Reduce 97.22% | 693 | $14.43 |
| Q2 2021 | +24,946 | New Buy | 24,946 | $17.12 |
| Q3 2020 | -9,617 | Sold Out | 0 | $0.00 |
| Q2 2020 | +1,853 | Add 23.87% | 9,617 | $33.27 |
| Q1 2020 | -953 | Reduce 10.93% | 7,764 | $35.68 |
| Q4 2019 | -1,708 | Reduce 16.38% | 8,717 | $44.05 |
| Q3 2019 | +898 | Add 9.43% | 10,425 | $22.54 |
| Q2 2019 | +5,285 | Add 124.59% | 9,527 | $41.99 |
| Q1 2019 | +4,242 | New Buy | 4,242 | $30.88 |
Renaissance Technologies (RenTech)'s Soleno Therapeutics Investment FAQs
Renaissance Technologies (RenTech) first purchased Soleno Therapeutics, Inc. (SLNO) in Q1 2019, acquiring 4,242 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Soleno Therapeutics, Inc. (SLNO) for 21 quarters since Q1 2019.
Renaissance Technologies (RenTech)'s largest addition to Soleno Therapeutics, Inc. (SLNO) was in Q1 2026, adding 447,300 shares worth $14.98 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 447,300 shares of Soleno Therapeutics, Inc. (SLNO), valued at approximately $14.98 M.
As of the Q1 2026 filing, Soleno Therapeutics, Inc. (SLNO) represents approximately 0.02% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Soleno Therapeutics, Inc. (SLNO) was 447,300 shares, as reported at the end of Q1 2026.